Concepedia

Vladimir Lesovoy

VL

8

Publications

4.8K

Citations

8

H-Index

2005

Active since

Affiliations

Aarhus University Hospital(Current)

University of Modena and Reggio Emilia

National Agency for New Technologies, Energy and Sustainable Economic Development

Aarhus University

Malmö University

Vladimir Lesovoy is an author at Aarhus University Hospital specializing in cancer therapeutics, urology, and pharmacotherapy.

Top concepts

Publications per year

2005–2013

8

Publications

8

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 3.6K citations

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

Robert J. Motzer, Dmitry Nosov, Timothy Eisen et al. · Journal of Clinical Oncology · 2013 · 438 citations · Full text

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial

Thomas E. Hutson, Vladimir Lesovoy, V.P. Stus et al. · The Lancet Oncology · 2013 · 404 citations

, , +8

Semen Quality and Exposure to Persistent Organochlorine Pollutants

Gunnar Toft, Anna Rignell‐Hydbom, E Tyrkiel et al. · Epidemiology · 2006 · 129 citations · Full text

Reproductive Hormone Levels in Men Exposed to Persistent Organohalogen Pollutants: A Study of Inuit and Three European Cohorts

Aleksander Giwercman, Anna Rignell‐Hydbom, Gunnar Toft et al. · Environmental Health Perspectives · 2006 · 61 citations · Full text

Rows per page

1–5 of 8